Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy

Mov Disord. 2017 Jan;32(1):170-171. doi: 10.1002/mds.26727. Epub 2016 Aug 1.

Authors

Jochen Hammes¹, Gérard N Bischof^{1

2}, Kathrin Giehl¹, Jennifer Faber^{3

4}, Alexander Drzezga^{1

4}, Thomas Klockgether^{3

4}, Thilo van Eimeren^{1

2

4}

Affiliations

¹ Multimodal Neuroimaging Group, Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
² Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Germany.
³ Department of Neurology, University of Bonn, Bonn, Germany.
⁴ German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.

PMID: 27476874
DOI: 10.1002/mds.26727

No abstract available

Keywords: PSP; Richardson syndrome; atypical parkinsonism; tau PET.

Publication types

Case Reports
Letter

MeSH terms

Aged
Basal Ganglia / diagnostic imaging
Basal Ganglia / metabolism
Carbolines / metabolism*
Humans
Magnetic Resonance Imaging
Male
Positron-Emission Tomography / methods*
Supranuclear Palsy, Progressive / diagnostic imaging*
Supranuclear Palsy, Progressive / metabolism*
Tomography, Emission-Computed, Single-Photon
tau Proteins / metabolism

Substances

Carbolines
tau Proteins
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole